These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 8097579

  • 41. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J, Usui T, Tsukada T, Nakai Y, Koh T, Ishihara T, Tanaka I, Uchida K, Yoshimasa T, Nakano R.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [Abstract] [Full Text] [Related]

  • 42. CSF corticotropin releasing hormone, somatostatin, and thyrotropin releasing hormone in schizophrenia.
    Banki CM, Karmacsi L, Bissette G, Nemeroff CB.
    Psychiatry Res; 1992 Jul; 43(1):13-21. PubMed ID: 1359593
    [Abstract] [Full Text] [Related]

  • 43. [Corticotropin-releasing factor concentrations in cerebrospinal fluid and its diurnal rhythm in patients with Cushing's disease].
    Yokoe T, Kuwayama A, Ichihara K, Yamamoto N, Kageyama N.
    Nihon Naibunpi Gakkai Zasshi; 1984 Aug 20; 60(8):964-70. PubMed ID: 6334621
    [Abstract] [Full Text] [Related]

  • 44. Corticotropin-releasing hormone production by a small cell carcinoma in a patient with ACTH-dependent Cushing's syndrome.
    Auchus RJ, Mastorakos G, Friedman TC, Chrousos GP.
    J Endocrinol Invest; 1994 Jun 20; 17(6):447-52. PubMed ID: 7930390
    [Abstract] [Full Text] [Related]

  • 45. Clinical studies with corticotropin releasing factor: implications for the diagnosis and pathophysiology of depression, Cushing's disease, and adrenal insufficiency.
    Gold PW, Chrousos GP.
    Psychoneuroendocrinology; 1985 Jun 20; 10(4):401-19. PubMed ID: 3878972
    [Abstract] [Full Text] [Related]

  • 46. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
    Lee TI, Lin SY, Won JG, Tang KT, Jap TS, Kwok CF, Lin HD.
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct 20; 65(10):474-82. PubMed ID: 12523812
    [Abstract] [Full Text] [Related]

  • 47. Corticotropin releasing factor: a new tool for the differential diagnosis of Cushing's syndrome.
    Müller OA, Stalla GK, von Werder K.
    J Clin Endocrinol Metab; 1983 Jul 20; 57(1):227-9. PubMed ID: 6304135
    [Abstract] [Full Text] [Related]

  • 48. Cushing's syndrome due to ectopic CRH secretion by adrenal pheochromocytoma accompanied by renal infarction.
    Bayraktar F, Kebapcilar L, Kocdor MA, Asa SL, Yesil S, Canda S, Demir T, Saklamaz A, Seçil M, Akinci B, Yener S, Comlekci A.
    Exp Clin Endocrinol Diabetes; 2006 Sep 20; 114(8):444-7. PubMed ID: 17039427
    [Abstract] [Full Text] [Related]

  • 49. Corticotropin releasing hormone stimulation test: diagnostic aspects in Cushing's syndrome.
    Boscaro M, Rampazzo A, Sonino N, Merola G, Scanarini M, Mantero F.
    J Endocrinol Invest; 1987 Jun 20; 10(3):297-302. PubMed ID: 3040851
    [Abstract] [Full Text] [Related]

  • 50. Immunoreactive corticotropin-releasing factor concentrations in cerebrospinal fluid from patients with hypothalamic-pituitary-adrenal disorders.
    Tomori N, Suda T, Tozawa F, Demura H, Shizume K, Mouri T.
    J Clin Endocrinol Metab; 1983 Dec 20; 57(6):1305-7. PubMed ID: 6605358
    [Abstract] [Full Text] [Related]

  • 51. FK 33-824, a met-enkephalin analog, blocks corticotropin-releasing hormone-induced adrenocorticotropin secretion in normal subjects but not in patients with Cushing's disease.
    Allolio B, Deuss U, Kaulen D, Leonhardt U, Kallabis D, Hamel E, Winkelmann W.
    J Clin Endocrinol Metab; 1986 Dec 20; 63(6):1427-31. PubMed ID: 3023423
    [Abstract] [Full Text] [Related]

  • 52. [Pseudo-Cushing syndrome. Physiopathologic aspects and differential diagnosis].
    Ceroni L, Cota D, Pasquali R.
    Minerva Endocrinol; 2000 Jun 20; 25(2):47-54. PubMed ID: 11189791
    [Abstract] [Full Text] [Related]

  • 53. CSF corticotropin-releasing hormone in depressed patients and normal control subjects.
    Roy A, Pickar D, Paul S, Doran A, Chrousos GP, Gold PW.
    Am J Psychiatry; 1987 May 20; 144(5):641-5. PubMed ID: 3495188
    [Abstract] [Full Text] [Related]

  • 54. Diurnal variation of cerebrospinal fluid immunoreactive corticotropin-releasing hormone levels in healthy volunteers.
    Kling MA, DeBellis MD, O'Rourke DK, Listwak SJ, Geracioti TD, McCutcheon IE, Kalogeras KT, Oldfield EH, Gold PW.
    J Clin Endocrinol Metab; 1994 Jul 20; 79(1):233-9. PubMed ID: 8027234
    [Abstract] [Full Text] [Related]

  • 55. Corticotropin-releasing hormone and adrenocorticotropic hormone concentrations in cerebrospinal fluid of dogs with pituitary-dependent hyperadrenocorticism.
    Van Wijk PA, Rijnberk A, Croughs RJ, Voorhout G, Sprang EP, Mol JA.
    Endocrinology; 1992 Dec 20; 131(6):2659-62. PubMed ID: 1332844
    [Abstract] [Full Text] [Related]

  • 56. Effects of the combined administration of hexarelin, a synthetic peptidyl GH secretagogue, and hCRH on ACTH, cortisol and GH secretion in patients with Cushing's disease.
    Arvat E, Ramunni J, Giordano R, Maccagno B, Broglio F, Benso A, Deghenghi R, Ghigo E.
    J Endocrinol Invest; 1999 Jan 20; 22(1):23-8. PubMed ID: 10090133
    [Abstract] [Full Text] [Related]

  • 57. Depression and endocrine disorders: focus on the thyroid and adrenal system.
    Musselman DL, Nemeroff CB.
    Br J Psychiatry Suppl; 1996 Jun 20; (30):123-8. PubMed ID: 8864158
    [Abstract] [Full Text] [Related]

  • 58. Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy.
    Magiakou MA, Mastorakos G, Oldfield EH, Gomez MT, Doppman JL, Cutler GB, Nieman LK, Chrousos GP.
    N Engl J Med; 1994 Sep 08; 331(10):629-36. PubMed ID: 8052272
    [Abstract] [Full Text] [Related]

  • 59. Evidence for two subtypes of Cushing's disease based on the analysis of episodic cortisol secretion.
    Van Cauter E, Refetoff S.
    N Engl J Med; 1985 May 23; 312(21):1343-9. PubMed ID: 3873008
    [Abstract] [Full Text] [Related]

  • 60. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM, Kaltsas GA, Mohammed S, Morris DG, Jenkins P, Chew SL, Monson JP, Besser GM, Grossman AB.
    J Clin Endocrinol Metab; 2003 Nov 23; 88(11):5299-306. PubMed ID: 14602765
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.